Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study-Reference-Cited by-同舟云学术

Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study

Published:2022-01-08 Issue: Volume: Page:
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Rannikko Antti¹²^ORCID,Leht Mare³⁴,Mirtti Tuomas²⁵^ORCID,Kenttämies Anu⁶^ORCID,Tolonen Teemu⁷^ORCID,Rinta‐Kiikka Irina⁸^ORCID,Kilpeläinen Tuomas P.¹²^ORCID,Natunen Kari⁹^ORCID,Lilja Hans¹⁰¹¹^ORCID,Lehtimäki Terho¹²^ORCID,Raitanen Jani⁹¹³^ORCID,Kujala Paula⁷,Ronkainen Johanna⁸,Matikainen Mika¹^ORCID,Petas Anssi¹^ORCID,Taari Kimmo¹^ORCID,Tammela Teuvo³¹⁴^ORCID,Auvinen Anssi⁹^ORCID

Affiliation:

1. Department of Urology Faculty of Medicine Helsinki University HospitalUniversity of HelsinkiHelsinkiFinland

2. Research Programme in Systems Oncology Faculty of Medicine University of Helsinki HelsinkiFinland

3. Faculty of Medicine and Health Technology Tampere University TampereFinland

4. Department of Urology Hyvinkää Hospital Helsinki and Uusimaa Hospital District HyvinkääFinland

5. Pathology HUS Diagnostic Centre HUS Medical Imaging Centre Helsinki Finland

6. Radiology HUS Diagnostic Centre HUS Medical Imaging Centre HelsinkiFinland

7. Department of Pathology Fimlab Laboratories TampereFinland

8. Department of Radiology Tampere University Hospital TampereFinland

9. Faculty of Social Sciences Tampere University Tampere Finland

10. Departments of Laboratory Medicine, Surgery, and Medicine Memorial Sloan Kettering Cancer Center New York NY USA

11. Department of Translational Medicine Lund University Malmö Sweden